Abstract
Objective: To systematically review the literature to characterize radiation-induced sensorineural hearing loss for head and neck tumors.
Method: Seven databases were searched to identify studies assessing the characteristics of sensorineural hearing loss caused exclusively by radiotherapy for head and neck cancer.
Results: Fourteen articles were evaluated. The reported incidence of sensorineural hearing loss was higher on frequencies above 4 Hz (up to 95%) when compared to the speech frequencies. Radiation dose and follow-up time were important factors affecting incidence rates.
Conclusion: Evidence demonstrates that the resulting SNHL is irreversible, progressive, and dose-dependent. High-quality literature regarding SNHL due to radiotherapy is lacking. Improved evaluation protocols should be adopted in the standard of care for patients undergoing radiotherapy.
Get full access to this article
View all access options for this article.